Structures of the σ2 receptor enable docking for bioactive ligand discoveryΣ2受体的结构可以对接生物活性配体的发现NatureIF48.52021-12-080PRE
Property-Unmatched Decoys in Docking BenchmarksJOURNAL OF CHEMICAL INFORMATION AND MODELINGIF5.32021-01-2566OA
Selectivity Challenges in Docking Screens for GPCR Targets and AntitargetsJOURNAL OF MEDICINAL CHEMISTRYIF6.82018-07-1033OAAI
Design, Synthesis, and Biological Evaluation of Pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance MutationJOURNAL OF MEDICINAL CHEMISTRYIF6.82018-06-1531PREAI
Structure-Guided Design of C4-alkyl-1,4-dihydro-2H-pyrimido[4,5-d][1,3]oxazin-2-ones as Potent and Mutant-Selective Epidermal Growth Factor Receptor (EGFR) L858R/T790M InhibitorsSCIENTIFIC REPORTSIF3.92017-06-199OAAI
Discovery and Rational Design of Pteridin-7(8H)-one-Based Inhibitors Targeting FMS-like Tyrosine Kinase 3 (FLT3) and Its MutantsJOURNAL OF MEDICINAL CHEMISTRYIF6.82016-06-2229PREAI
Antiproliferative and apoptosis-inducing activities of novel naphthalimide-cyclam conjugates through dual topoisomerase (topo) I/II inhibitionBIOORGANIC & MEDICINAL CHEMISTRYIF32015-09-0128PREAI